We sought to investigate novel role of mTOR in glucose to lipid metabolism in breast cancer, particularly those governed by mTORC2, a key component of HER2, PI3K pathway and is resistant to rapalog therapy. This evidence concerns the gene PIK3CA and breast carcinoma.